4.7 Article

Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host

Journal

CLINICAL IMMUNOLOGY
Volume 131, Issue 3, Pages 395-403

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2009.02.002

Keywords

Human cytomegalovirus; T-cell response; Primary infection; Immunocompromised patients; Pregnant women

Categories

Funding

  1. Ministero delta Salute
  2. Fondazione IRCCS Policlinico San Matteo Ricerca Corrente [80541, 80513, 80425]
  3. Ricerca Finalizzata [89301]
  4. Fondazione CARIPLO [93005]

Ask authors/readers for more resources

The kinetics of primary human cytomegalovirus (HCMV) infection and specific T-cell responses were investigated in 16 immunocompetent pregnant women and 8 solid-organ transplant recipients (SOTR). T-cell responses to whole HCMV and to pp65 and IE-1 peptides were determined by flow cytometry evaluation of IFN gamma production. HCMV-specific CD4(+) and CD8(+) T-cells appeared earlier and simultaneously in immunocompetent subjects, whereas specific CD8(+) T-cells preceded CD4(+) T-cells in half of the SOTR examined. The magnitude of the HCMV-specific T-cell pool was comparable. HCMV load reached peak levels 100-1000 times higher in SOTR than in immunocompetent women, while the virus persisted for months in blood of both groups. T-cells directed to pp65 and IE-1 were only detected in a portion of subjects developing a full T-cell response to the whole virus. Thus, the development of cell-mediated immune response in primary HCMV infection may be missed when looking at pp65 and IE-1 peptide-stimulated T-cells only. (C) 2009 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

Human cytomegalovirus non-primary infection during pregnancy: antibody response, risk factors and newborn outcome

Paola Zelini, Piera d'Angelo, Marica De Cicco, Cristian Achille, Antonella Sarasini, Loretta Fiorina, Daniela Cirasola, Valentina Marazzi, Stefania Piccini, Milena Furione, Alessia Arossa, Giulia Muscettola, Arsenio Spinillo, Daniele Lilleri

Summary: This study investigates the frequency and characteristics of non-primary infection of human cytomegalovirus (HCMV) in pregnant women. The findings suggest that non-primary infection is common during pregnancy, but the risk of congenital infection is low. The study also examines the transmission routes and immune response during pregnancy.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Immunology

Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study)

Daniele Lilleri, Beatrice Tassis, Lorenza Pugni, Andrea Ronchi, Carlo Pietrasanta, Arsenio Spinillo, Alessia Arossa, Cristian Achille, Patrizia Vergani, Sara Ornaghi, Silvia Riboni, Paolo Cavoretto, Massimo Candiani, Gerarda Gaeta, Federico Prefumo, Nicola Fratelli, Anna Fichera, Michele Vignali, Allegra Barbasetti Di Prun, Elisa Fabbri, Irene Cetin, Anna Locatelli, Sara Consonni, Simona Rutolo, Elena Miotto, Valeria Savasi, Maria Di Giminiani, Antonella Cromi, Sandro Binda, Loretta Fiorina, Milena Furione, Gabriela Cassinelli, Catherine Klersy

Summary: Newborns from women with preconception immunity have a low rate of cCMV infection, mostly due to reactivation of the latent virus. Therefore, serological screening in childbearing age would be pivotal to identify HCMV-seropositive women with a low risk of cCMV in their newborns.

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients

Irene Cassaniti, Marilena Gregorini, Federica Bergami, Francesca Arena, Jose Camilla Sammartino, Elena Percivalle, Ehsan Soleymaninejadian, Massimo Abelli, Elena Ticozzelli, Angela Nocco, Francesca Minero, Eleonora Francesca Pattonieri, Daniele Lilleri, Teresa Rampino, Fausto Baldanti

Summary: This study investigated the role of a third dose of the BNT162b2 vaccine in kidney transplant recipients. The researchers found an increased immune response, especially in terms of T cell response to the Spike protein, after the third dose. However, the seroconversion rate remained below 50%. Mycophenolate treatment, steroid administration, and age appeared to be associated with a poor immune response.

VACCINES (2022)

Article Medicine, General & Internal

Performance of Whole Blood Stimulation Assays for the Quantification of SARS-CoV-2 Specific T-Cell Response: A Cross-Sectional Study

Federica Bergami, Francesca Arena, Eleonora Francesca Pattonieri, Marilena Gregorini, Federica Meloni, Massimo Abelli, Elena Ticozzelli, Giorgia Testa, Daniele Lilleri, Irene Cassaniti, Fausto Baldanti

Summary: This study compared two different testing methods for the T-cell response in COVID-19 vaccinated individuals. The home-made whole blood stimulation assay was found to have good correlation with the standardized ELISpot assay, although a higher percentage of immunocompromised subjects tested positive using the ELISpot assay. Additionally, the home-made assay showed good agreement with three commercial assays in terms of both positive and negative results.

DIAGNOSTICS (2022)

Article Immunology

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers

Federica Bergami, Francesca Arena, Jose Camilla Sammartino, Alessandro Ferrari, Federica Zavaglio, Paola Zelini, Stefania Paolucci, Giuditta Comolli, Elena Percivalle, Daniele Lilleri, Irene Cassaniti, Fausto Baldanti

Summary: We reported the long-term kinetics of immune response after vaccination and evaluated the immunogenicity after a third dose of mRNA vaccine. The results showed that the antibody titer after the third dose was significantly higher than after the second dose, T-cell mediated response reached positive levels, and memory B cells remained. This indicates that a third dose can enhance the immune response.

VACCINES (2022)

Article Biochemistry & Molecular Biology

Association between Vitamin D Serum Levels and Immune Response to the BNT162b2 Vaccine for SARS-CoV-2

Paola Zelini, Piera D'Angelo, Emanuele Cereda, Catherine Klersy, Peressini Sabrina, Riccardo Albertini, Giuseppina Grugnetti, Anna Maria Grugnetti, Carlo Marena, Sara Cutti, Daniele Lilleri, Irene Cassaniti, Baldanti Fausto, Riccardo Caccialanza

Summary: The levels of vitamin D are associated with the immune response elicited by the BNT162b2 vaccine, and adequate levels of vitamin D may improve the vaccine's effectiveness.

BIOMEDICINES (2022)

Letter Dermatology

Dynamics of humoral and cellular immunity elicited by the BNT162b2 mRNA vaccine in psoriatic patients under targeted immunosuppression: A longitudinal cohort study

Paola Zelini, Eugenio Isoletta, Martina Volonte, Daniele Lilleri, Irene Cassaniti, Valeria Musella, Catherine Klersy, Fausto Baldanti, Valeria Brazzelli

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Microbiology

Fifteen-Year Surveillance of LTR Receiving Pre-Emptive Therapy for CMV Infection: Prevention of CMV Disease and Incidence of CLAD

Davide Piloni, Elisa Gabanti, Monica Morosini, Gabriela Cassinelli, Vanessa Frangipane, Federica Zavaglio, Tiberio Oggionni, Laura Saracino, Sara Lettieri, Eloisa Arbustini, Federica Meloni, Daniele Lilleri

Summary: Pre-emptive therapy is highly effective in preventing CMV disease in lung transplant recipients and does not lead to a higher incidence of chronic lung allograft dysfunction (CLAD) compared to other cohorts receiving extended antiviral prophylaxis.

MICROORGANISMS (2022)

Article Biochemistry & Molecular Biology

Fibroblast, Epithelial and Endothelial Cell-Derived Human Cytomegalovirus Strains Display Distinct Neutralizing Antibody Responses and Varying Levels of gH/gL Complexes

Chiara Fornara, Eric Schultz, Daniele Lilleri, Fausto Baldanti, Brent Ryckman, Giuseppe Gerna

Summary: The serum neutralizing activity against HCMV varies depending on the producer cell type and the PC/TC ratio of virus preparations. The blocking activity of specific inhibitors also varies according to the PC/TC ratio. There is a potential producer cell effect on virus phenotype, but genetic factors cannot be overlooked. These findings have important implications for therapeutic antibodies and subunit vaccines.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Applied

Yet another in vitro evidence that natural compounds introduced by diet have anti-amyloidogenic activities and can counteract neurodegenerative disease depending on aging

Anna Lia Asti, Stefania Crespi, Teresa Rampino, Paola Zelini, Marilena Gregorini, Alessia Pascale, Nicoletta Marchesi, Stefania Saccucci, Carla Colombani, Sara Vitalini, Marcello Iriti

Summary: A major issue in Alzheimer's disease research is finding new drugs to decrease A beta aggregation. This study evaluated the in vitro inhibition of A beta(1-42) fibrillogenesis with natural compounds. Rutin showed the best inhibitory effect compared to other compounds.

NATURAL PRODUCT RESEARCH (2023)

Article Virology

Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients

Stelvio Tonello, Davide D'Onghia, Daria Apostolo, Erica Matino, Martina Costanzo, Giuseppe Francesco Casciaro, Alessandro Croce, Eleonora Rizzi, Erika Zecca, Anita Rebecca Pedrinelli, Veronica Vassia, Paolo Ravanini, Maria Grazia Crobu, Manuela Rizzi, Raffaella Landi, Luigi Mario Castello, Rosalba Minisini, Gian Carlo Avanzi, Mario Pirisi, Daniele Lilleri, Mattia Bellan, Donato Colangelo, Pier Paolo Sainaghi

Summary: This study aimed to evaluate osteopontin (OPN) as a potential biomarker for predicting the prognosis of COVID-19 patients. The results showed that higher plasma concentrations of OPN at hospital admission were associated with a worsening clinical condition. OPN levels might serve as a promising biomarker for early stratification of COVID-19 severity.

VIRUSES-BASEL (2023)

Article Microbiology

Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns

Paola Zelini, Piera d'Angelo, Federica Zavaglio, Ehsan Soleymaninejadian, Liliana Mariani, Francesca Perotti, Mattia Dominoni, Stelvio Tonello, Pierpaolo Sainaghi, Rosalba Minisini, Daria Apostolo, Daniele Lilleri, Arsenio Spinillo, Fausto Baldanti

Summary: In this prospective study, it was found that vaccinated pregnant women and their newborns had higher levels of cytokines and immune responses after SARS-CoV-2 infection. Additionally, the newborns of vaccinated mothers had higher levels of specific antibodies. Vaccination can enhance the immune profile of pregnant women and provide immune protection to newborns.

PATHOGENS (2023)

Article Virology

Correlates of postnatal human cytomegalovirus transmission in term babies in the first year

Piera d'Angelo, Paola Zelini, Federica Zavaglio, Stefania Piccini, Daniela Cirasola, Alessia Arossa, Arsenio Spinillo, Daniele Lilleri, Fausto Baldanti

Summary: This study investigated the rates and routes of HCMV transmission in full-term infants during the first year of life. The findings showed that approximately one out of five infants developed HCMV infection within the first year, with breastmilk being the major route of transmission while maternal saliva and vaginal secretions played a minor role.

JOURNAL OF MEDICAL VIROLOGY (2023)

No Data Available